Press Release21 April 2021
S Hotels & Resorts Books THB 182 Million From Divestment Of UK Hotels, In Line With Portfolio Enhancement Strategy
Company remains fully committed to the UK market with plans to reinvest sale funds in the renovation of its top-tier hotels in the country, following significant THB 560m investments in February 2021
share this article
S Hotels & Resorts Chief Executive Officer, Dirk De Cuyper Photo: S Hotels & Resorts
S Hotels and Resorts Public Company Limited (SET: SHR), the flagship hospitality arm of Singha Estate PCL (SET: S), has disclosed its intention to divest a selection of its underperforming hotel assets in the United Kingdom, as part of its strategy to optimise its UK portfolio and maximise returns.
Executive summary: Economic review & outlook Thai economy in 1Q21: Regarding the recurrent wave of COVID-19 infection in December 2020, the growth of economic activities decelerated from the expected pace of continuous rebound even with much less strict outbreak controlling measures compared to the enforced nationwide lockdown in the first outbreak last year. Private consumption accordingly contracted from the drags of weak employment situation, uncertain personal incomes and declining consumer confidence. Despite these fragile conditions, there were still supports from government s stimulus measures such as co-payment subsidy program and financial aid scheme, totally amounting to more than 2,000 billion baht, which helped sustain households consumptions. Meanwhile, tourism sector overall remained in contraction due to the prolonging cross-border travel restriction and the decline in domestic tourism at the beginning of the year. With the rebounds of trading partner
PTT Invests in Lotus Pharmaceutical s Strategic Partnership in South East Asia
Tuesday, April 20, 2021 10:30AM IST (5:00AM GMT)
The transaction creates a very strong platform to expand market access in the ASEAN region.
Both parties are committed to further collaboration to provide patients with better access to high quality medicines across the region.
Lotus Pharmaceutical Co., Ltd. (“Lotus” or “the Company”, Taiwan TWSE ticker: 1795), an Alvogen company, has announced the issuance of new shares through private placement to be acquired by Innobic (Asia). The move is aimed at further strengthening the company’s market access in the ASEAN region. Innobic (Asia) is a wholly owned subsidiary of PTT Public Company Limited (“PTT”, SET ticker: PTT), the largest publicly listed conglomerate in Thailand. PTT, whose majority owner is the Ministry of Finance in Thailand, is the nation s only company listed in the Fortune Global 500.
disease 2019 (COVID-19) for the 2021 Annual General Meeting of Shareholders To: The Stock Exchange of Thailand Reference: TMB Bank Public Company Limited s Letter No. ST. 005/2564 dated February 24, 2021 Reference is made to the resolutions of the Board of Directors of TMB Bank Public Company Limited (the Bank ) to hold the 2021 Annual General Meeting of Shareholders on Friday, April 23, 2021 at 14:00 at the Auditorium, 7th Floor, TMB Head Office, No. 3000, Phahon Yothin Road, Chom Phon Sub- district, Chatuchak District, Bangkok, as detailed in the above referred document. However, the Coronavirus disease 2019 (COVID-19) has spread widely in various areas currently with increasing clusters of individuals becoming infected from public gatherings.
PTT Invests in Lotus Pharmaceutical s Strategic Partnership in South East Asia apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.